Intracranial Stenosis: Impact of Randomized Trials on Treatment Preferences of US Neurologists and Neurointerventionists | Zendy

Tanya N. Turan | Zendy; George Cotsonis | Zendy; Michael Lynn | Zendy; Rahim H. Wooley | Zendy; Seegar Swanson | Zendy; Janice E. Williams | Zendy; Barney J. Stern | Zendy; Colin P. Derdeyn | Zendy; David Fiorella | Zendy; Marc I. Chimowitz | Zendy

Open Access

Intracranial Stenosis: Impact of Randomized Trials on Treatment Preferences of US Neurologists and Neurointerventionists

Author(s) -

Tanya N. Turan,

George Cotsonis,

Michael Lynn,

Rahim H. Wooley,

Seegar Swanson,

Janice E. Williams,

Barney J. Stern,

Colin P. Derdeyn,

David Fiorella,

Marc I. Chimowitz

Publication year - 2014

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000358120

Subject(s) - medicine , aspirin , stroke (engine) , randomized controlled trial , warfarin , stenosis , clinical trial , emergency medicine , atrial fibrillation , mechanical engineering , engineering

Medical and endovascular treatment options for stroke prevention in patients with symptomatic intracranial stenosis have evolved over the past several decades, but the impact of 2 major multicenter randomized stroke prevention trials on physician practices has not been studied. We sought to determine changes in US physician treatment choices for patients with intracranial atherosclerotic stenosis (ICAS) following 2 NIH-funded clinical trials that studied medical therapies (antithrombotic agents and risk factor control) and percutaneous transluminal angioplasty and stenting (PTAS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research